MARETTI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.334
AS - Asia 4.529
EU - Europa 4.038
SA - Sud America 705
AF - Africa 99
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.761
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.174
SG - Singapore 1.417
GB - Regno Unito 1.137
CN - Cina 1.117
IT - Italia 995
VN - Vietnam 618
BR - Brasile 549
HK - Hong Kong 533
SE - Svezia 495
DE - Germania 311
FR - Francia 209
RU - Federazione Russa 196
FI - Finlandia 173
IN - India 162
KR - Corea 137
UA - Ucraina 123
TR - Turchia 95
CA - Canada 83
BG - Bulgaria 65
ID - Indonesia 65
NL - Olanda 65
BE - Belgio 63
AR - Argentina 62
JP - Giappone 61
BD - Bangladesh 59
MX - Messico 50
PL - Polonia 42
AU - Australia 38
IQ - Iraq 37
PK - Pakistan 31
IR - Iran 26
EC - Ecuador 24
LT - Lituania 23
ZA - Sudafrica 23
ES - Italia 22
AE - Emirati Arabi Uniti 20
PH - Filippine 20
CL - Cile 19
IE - Irlanda 19
CO - Colombia 17
KE - Kenya 16
MY - Malesia 15
MA - Marocco 14
VE - Venezuela 13
AZ - Azerbaigian 12
UZ - Uzbekistan 12
TW - Taiwan 11
AT - Austria 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
EG - Egitto 9
IL - Israele 9
JO - Giordania 9
TH - Thailandia 9
CH - Svizzera 8
NP - Nepal 8
PE - Perù 8
RO - Romania 8
RS - Serbia 8
HU - Ungheria 7
PT - Portogallo 7
PY - Paraguay 7
GR - Grecia 6
KZ - Kazakistan 6
MD - Moldavia 6
SA - Arabia Saudita 6
BY - Bielorussia 5
DK - Danimarca 5
DZ - Algeria 5
GE - Georgia 5
JM - Giamaica 5
EE - Estonia 4
EU - Europa 4
HR - Croazia 4
LK - Sri Lanka 4
LV - Lettonia 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
AL - Albania 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
LB - Libano 3
ML - Mali 3
MN - Mongolia 3
PA - Panama 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
Totale 16.733
Salva come PNG Salva come JPEG
Città #
Singapore 909
Santa Clara 811
Ashburn 721
Southend 721
Fairfield 570
Chandler 541
Hong Kong 516
San Jose 360
Woodbridge 356
Nyköping 257
Hefei 249
Dearborn 240
Houston 233
Ann Arbor 225
Beijing 224
Wilmington 217
Modena 209
Jacksonville 207
Ho Chi Minh City 196
Seattle 190
London 177
Cambridge 175
Hanoi 151
Los Angeles 128
The Dalles 127
Helsinki 126
Seoul 120
Council Bluffs 106
New York 94
Milan 64
Princeton 62
Moscow 60
Lauterbourg 58
Sofia 58
San Diego 54
Bremen 53
Redwood City 51
Frankfurt am Main 50
Eugene 48
Fremont 43
Shanghai 42
São Paulo 42
Izmir 40
Da Nang 38
Tokyo 38
Brussels 36
Buffalo 36
Jakarta 36
Chicago 34
Columbus 33
Warsaw 33
Ottawa 31
Munich 30
Orem 29
Dallas 28
Rome 27
Bologna 26
Chennai 24
Haiphong 23
Mexico City 22
Mumbai 22
Parma 22
Porto Alegre 22
Rio de Janeiro 22
Basingstoke 20
Montreal 20
Amsterdam 19
Denver 19
Sydney 19
Falls Church 18
Guangzhou 18
Atlanta 15
Hangzhou 15
New Delhi 15
San Francisco 15
Dublin 13
Johannesburg 13
Nanjing 13
Napoli 13
Quito 13
Reggio Nell'emilia 13
Belo Horizonte 12
Kunming 12
La Puente 12
Lappeenranta 12
Nairobi 12
Nuremberg 12
Baghdad 11
Dhaka 11
Gurgaon 11
Hyderabad 11
Kent 11
Belfast 10
Biên Hòa 10
Brooklyn 10
Formigine 10
Naples 10
Phoenix 10
Salt Lake City 10
Tashkent 10
Totale 10.971
Salva come PNG Salva come JPEG
Nome #
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 407
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 395
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 388
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 371
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 370
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 363
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 344
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 344
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 336
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 328
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 325
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 316
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 314
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 308
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 302
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 297
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 290
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 284
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 278
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 277
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 273
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 272
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 271
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 265
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 260
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 259
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 255
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 247
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 246
Aerodynamic performance of lipid-based nanocarrier functionalized by novel mannose derivatives for Rifampicin intramacrophagic delivery 242
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 242
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 241
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 239
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 236
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 234
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 232
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 231
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 225
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 220
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 217
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 209
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 208
Formulazione per veicolare principi attivi lipofili 206
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 205
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 204
PASSIVE AND ACTIVE TARGETING TO MACROPHAGES USING LIPID NANOPARTICLES ASSEMBLIES FOR ANTI-TB THERAPY BY PULMONARY ROUTE 189
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 185
Medicinal Chemistry drives drug targeted delivery: a successful interplay 183
The improvement of Solid Lipid Microparticle breathability for an anti-TB inhalation therapy 177
In vivo β-carotene skin permeation modulated by Nanostructured Lipid Carriers 175
Nasal biocompatible powder of geraniol oil complexed with cyclodextrins for neurodegenerative diseases: Physicochemical characterization and in vivo evidences of nose to brain delivery 173
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 169
Solid Lipid Microparticles for inhaled anti-TB therapy by DPI: influence of the production process on drug stability and powder breathability 166
Inhaled micro- or nanoparticles: which are the best for intramacrophagic anti-infectious therapies? 164
Nuove molecole funzionalizzanti per il targeting ai macrofagi di vettori lipidici 163
Formulazione per veicolare principi attivi lipofili 162
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs 158
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 157
Combination of Nanodelivery Systems and Constituents Derived from Novel Foods: A Comprehensive Review 152
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 148
APPLICATION OF A NEW SURFACTANT FOR INHALED ANTI-INFLAMMATORY DRUG DELIVERY SYSTEMS: FROM NANOCARRIER TO PURE NANODRUG FORMULATION 143
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 143
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 135
Plant Resin Delivery by Nanovectors as an Emerging Approach to Boost Solubility, Permeability and Bioavailability 129
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 120
Optimizing Formulation Conditions of PLGA Microparticles to Enhance Indomethacin Encapsulation 115
Inhaled lipid nanoparticles: a feasible tool for a challenging route 114
IMMOBILIZATION OF HEPARIN BY TERNARY POLYELECTROLYTE COMPLEXES: A PRELIMINARY STUDY 100
ENGINEERING OF DRUG DELIVERY SYSTEMS TO ENHANCE DRUG POTENTIAL: FROM BEADS TO POLYMER-FREE NANOPARTICLES 93
Physicochemical characterization of SLN/Liposomes hybrid nanoparticles for the co-delivery of two antitubercular drugs: focus on SANS analysis 92
Lipid Nanodrugs for topical anti-inflammatory treatment of psoriasis: in vivo studies 88
Dispositivo per la somministrazione intravaginale di batteri e loro metaboliti 83
New insights on Indomethacin and PLGA interaction for a rational design of microparticles to be administered via intra-articular route 83
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 78
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 73
Development of a Heparin-Loaded Polyelectrolyte Complex for pH-Responsive Wound Healing Applications 68
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 65
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 64
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 63
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 46
Totale 16.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 0 0 0 0 0 0 138 52
2021/20221.308 33 77 119 59 55 123 50 88 180 120 276 128
2022/20231.475 222 205 105 172 162 171 29 143 148 24 59 35
2023/2024863 34 67 69 94 174 106 70 74 18 28 50 79
2024/20253.311 78 30 118 227 601 429 311 249 359 156 342 411
2025/20265.462 389 199 432 559 785 388 914 388 671 644 93 0
Totale 16.992